MedTrace Logo

Viability Testing and Transplantation of Marginal Livers

NCT02740608 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2022-03-11

No results posted yet for this study

Summary

This study is designed to determine if a rejected liver is viable using normothermic machine liver perfusion (NMLP). It aims to

1. establish the suitability of livers which have been declined by all UK liver transplant centres by monitoring their function on the NMLP machine; and,
2. transplant the liver if its function on the machine is satisfactory allowing it to be transplanted.

Conditions

  • Liver Transplantation

Interventions

DEVICE

OrganOx metra

Normothermic Machine Liver Perfusion

Sponsors & Collaborators

  • Wellcome Trust

    collaborator OTHER

  • University Hospital Birmingham NHS Foundation Trust

    collaborator OTHER

  • University of Birmingham

    lead OTHER

Principal Investigators

  • Darius Mirza · University Hospital Birmingham NHS Foundation Trust

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-06
Primary Completion
2018-05-08
Completion
2020-03-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02740608 on ClinicalTrials.gov